company background image
NUS logo

Nu Skin Enterprises NYSE:NUS Stock Report

Last Price

US$7.58

Market Cap

US$374.6m

7D

1.9%

1Y

-43.8%

Updated

19 May, 2025

Data

Company Financials

Nu Skin Enterprises, Inc.

NYSE:NUS Stock Report

Market Cap: US$374.6m

NUS Stock Overview

Engages in the development and distribution of various beauty and wellness products worldwide. More details

NUS fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends2/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Nu Skin Enterprises, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nu Skin Enterprises
Historical stock prices
Current Share PriceUS$7.58
52 Week HighUS$13.90
52 Week LowUS$5.32
Beta0.90
1 Month Change38.32%
3 Month Change4.26%
1 Year Change-43.77%
3 Year Change-83.14%
5 Year Change-78.64%
Change since IPO-73.63%

Recent News & Updates

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.06

May 12
Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.06

Revenues Working Against Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Following 28% Dive

Apr 23
Revenues Working Against Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Following 28% Dive

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Apr 17
Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Recent updates

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.06

May 12
Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.06

Revenues Working Against Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Following 28% Dive

Apr 23
Revenues Working Against Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Following 28% Dive

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Apr 17
Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Should You Investigate Nu Skin Enterprises, Inc. (NYSE:NUS) At US$7.34?

Mar 25
Should You Investigate Nu Skin Enterprises, Inc. (NYSE:NUS) At US$7.34?

Improved Revenues Required Before Nu Skin Enterprises, Inc. (NYSE:NUS) Stock's 27% Jump Looks Justified

Mar 06
Improved Revenues Required Before Nu Skin Enterprises, Inc. (NYSE:NUS) Stock's 27% Jump Looks Justified

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be $0.06

Feb 17
Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be $0.06

Here's Why Nu Skin Enterprises (NYSE:NUS) Is Weighed Down By Its Debt Load

Feb 15
Here's Why Nu Skin Enterprises (NYSE:NUS) Is Weighed Down By Its Debt Load

Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth

Jan 09

Nu Skin Enterprises (NYSE:NUS) Will Be Looking To Turn Around Its Returns

Dec 21
Nu Skin Enterprises (NYSE:NUS) Will Be Looking To Turn Around Its Returns

Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nov 12
Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation

Nov 12

The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Oct 04
The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Aug 31
Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Aug 13
Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

May 30
Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

May 13
Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Mar 28
Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty

Mar 04

We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Feb 22
We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Feb 19
Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Feb 18
Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Jan 18
Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Dec 14
Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nov 17
Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nu Skin: Is It Just A Growth Problem?

Oct 17

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Oct 09
Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Sep 27
When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Sep 12

Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Sep 08
Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Aug 05
Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Shareholder Returns

NUSUS Personal ProductsUS Market
7D1.9%0.5%2.9%
1Y-43.8%-21.7%11.9%

Return vs Industry: NUS underperformed the US Personal Products industry which returned -23.7% over the past year.

Return vs Market: NUS underperformed the US Market which returned 11.9% over the past year.

Price Volatility

Is NUS's price volatile compared to industry and market?
NUS volatility
NUS Average Weekly Movement8.5%
Personal Products Industry Average Movement9.6%
Market Average Movement8.1%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market4.2%

Stable Share Price: NUS has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: NUS's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19843,100Ryan Napierskiwww.nuskin.com

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+.

Nu Skin Enterprises, Inc. Fundamentals Summary

How do Nu Skin Enterprises's earnings and revenue compare to its market cap?
NUS fundamental statistics
Market capUS$374.55m
Earnings (TTM)-US$38.55m
Revenue (TTM)US$1.68b

0.2x

P/S Ratio

-9.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NUS income statement (TTM)
RevenueUS$1.68b
Cost of RevenueUS$505.72m
Gross ProfitUS$1.17b
Other ExpensesUS$1.21b
Earnings-US$38.55m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.78
Gross Margin69.88%
Net Profit Margin-2.30%
Debt/Equity Ratio31.7%

How did NUS perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

-31%

Payout Ratio

Does NUS pay a reliable dividends?

See NUS dividend history and benchmarks
When do you need to buy NUS by to receive an upcoming dividend?
Nu Skin Enterprises dividend dates
Ex Dividend DateMay 30 2025
Dividend Pay DateJun 11 2025
Days until Ex dividend11 days
Days until Dividend pay date23 days

Does NUS pay a reliable dividends?

See NUS dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 04:19
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nu Skin Enterprises, Inc. is covered by 11 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anand VankawalaAvondale Partners
Olivia Tong CheangBofA Global Research
April SceeBTIG